2011 - CTS-IXA


This page contains exclusive content for the member of the following sections: TTS, CTS, IXA. Log in to view.

Parallel Session 3- Genetic Engineering (Xeno Track)

5.123 - A comparison of the in vitro human immune response to corneal cells from humans and genetically-modified pigs

Presenter: Hidetaka, Hara, Pittsburgh, United States
Authors: Hidetaka Hara1, Naoko Koike1, Cassandra Long1, Minoru Fujita1, Danny S. Roh2, James L. Funderburgh2, Thomas E. Starzl1, Yifan Dai3, David L. Ayares3, David K.C. Cooper1

123

A comparison of the in vitro human immune response to corneal cells from humans and genetically-modified pigs

Hidetaka Hara1, Naoko Koike1, Cassandra Long1, Minoru Fujita1, Danny S. Roh2, James L. Funderburgh2, Thomas E. Starzl1, Yifan Dai3, David L. Ayares3, David K.C. Cooper1

1Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA; 2Eye & Ear Institute, University of Pittsburgh, Pittsburgh, PA; 3Revivicor Inc., Blacksburg, VA; United States

 

Purpose: To investigate in vitro the human (h) humoral and cellular responses to wild-type (WT) pig corneal endothelial cells (pCECs) and compare with CECs from h and genetically-engineered pigs – (i) α1,3-galactosyltransferase gene-knockout [GTKO], (ii) GTKO transgenic for hCD46 [GTKO/CD46], (iii) GTKO/CD46/CD55, (iv) dominant-negative class II transactivator knockdown [CIITA-DN].

Methods: Lysis of activated pCECs was determined by a h complement-dependent cytotoxicity (CDC) assay. The hCD4+T cell response to CECs from WT, GTKO, and GTKO/CD46 pigs and humans was measured by MLR. The expression of SLA class II on CIITA-DN pCECs with/without activation by IFN-γ was measured. MLR was also performed using PBMCs from WT, CIITA-DN pigs, and h.

Results: On CDC, when activated pCECs were used, there was no significant difference in lysis of WT and GTKO pCECs. However, GTKO/CD46 pCECs demonstrated significant resistance to lysis (p<0.05 vs WT and GTKO), and there was no lysis of GTKO/CD46/CD55 pCECs (p<0.05 vs GTKO/CD46). hCD4+T cell responses to GTKO and GTKO/CD46 pCECs and hCECs were significantly less than to WT pCECs before and after activation (p<0.01). Although the hCD4+T cell response to GTKO and GTKO/CD46 pCEC was greater than to hCECs before activation, there was no significant difference after activation. The expression of SLA class II on pCEC from CIITA-DN pigs was significantly down-regulated, even after activation, and the hCD4+T cell response to CIITA-DN cells was significantly lower than to h and WT cells (P<0.01).

Conclusions: Corneas from GTKO/CD46/CD55/CIITA-DN pigs (when available) should be significantly protected against h humoral and cellular immunity, and may be comparable to h corneas.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada